Dr Naureen Starling is a Consultant Medical Oncologist at The Royal Marsden specialising in treatment of gastrointestinal (GI) cancers, Associate Director of Clinical Research for the Royal Marsden, and is a Reader within the Division of Clinical Studies at the Institute of Cancer Research.
Her research interests are focused on earlier phase clinical trials, novel therapeutics/technologies, and the delivery of individualised medicine to patients with GI cancers. She is the principal investigator on numerous international clinical trials of novel drugs in oesophago-gastric, pancreatic, and colorectal cancer, a member of several multi-centre clinical trial steering and safety review committees and has been a lead or co-applicant on several successful peer-reviewed research grant applications including clinical research to bring liquid biopsies based on ctDNA to the clinic.
She serves on the UK NCRI colorectal and oesophago-gastric sub-groups and has acted as a clinical expert in oesophago-gastric and colorectal cancer for NICE, is a trustee for PCUK, has been a faculty member at ESMO and ASCO meetings, and is the Precision Therapeutics Theme Lead for RM/ICR NIHR BRC.